Bay Street News, September, 2024

Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader […]

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and […]

HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued […]

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine […]

ATHENS, Greece, Sept. 19, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing […]

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE: ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) (“Asante” […]

INCLINE VILLAGE, Nev., Sept. 19, 2024 (GLOBE NEWSWIRE) — Tri Pointe Homes, Inc. (NYSE: TPH), one of the largest homebuilders […]

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Verizon Business won the IBC Innovation Award for the implementation of Verizon […]

CARMEL, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology […]

NORTH PLAINS, Ore., Sept. 19, 2024 (GLOBE NEWSWIRE) — Jewett-Cameron Trading Company Ltd. (“Jewett-Cameron”) (Nasdaq: JCTCF), a company committed to […]